Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
Beliebteste Broker
News
- 13.07. - 12:00 Uhr
CannaPharmaRX, Inc. Closes Sale of Hanover Facility for $2,000,000 CAD
CALGARY, AB / ACCESSWIRE / July 13, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today the sale of its Hanover, Ontario facility for $2,000,000 CAD. The Hanover facility includes ten acres of land and 48,800 square feet of growing space. » Mehr auf accesswire.com
- 24.06. - 12:30 Uhr
CannaPharmaRx Comments on Stock Promotion Flag
CALGARY, AB / ACCESSWIRE / June 24, 2021 / CannaPharmaRx, Inc. (OTC PINK:CPMD) a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced that it has been brought to its attention that a Third Party has issued a Press Release. Management believes this update is from an unaffiliated third party posting information about the company. » Mehr auf accesswire.com
- 16.06. - 12:30 Uhr
CannaPharmaRX, Inc. Signs Agreement with Israeli Group K&K Consulting
Agreement Provides Exposure to Israeli Medicinal Cannabis Market CALGARY, AB / ACCESSWIRE / June 16, 2021 / CannapharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today it has formally executed an agreement with K&K Consulting to broaden its exposure to the medical cannabis market in Israel. Based upon current analyses, the cannabis patient numbers in Israel have reached a record high in 2020, with over 60,000 users. » Mehr auf accesswire.com
Unternehmenszahlen
(EUR) | Sep. 2022 | |
---|---|---|
Umsatz | 0,00 | - |
Bruttoeinkommen | 3,10k | - |
Nettoeinkommen | 2,08 Mio | - |
EBITDA | 522,71k | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 2,05 Mio € |
Anzahl Aktien | 257,57 Mio |
52 Wochen-Hoch/Tief | 0,0243 € - 0,00467 € |
Dividenden | Nein |
Beta | 0,25 |
KGV (PE Ratio) | 0,26 |
KGWV (PEG Ratio) | 0,0035 |
KBV (PB Ratio) | 0,14 |
KUV (PS Ratio) | 0,00 |
Unternehmensprofil
CannaPharmaRX, Inc. ist in der Cannabisbranche in Kanada tätig. Das Unternehmen verhandelt, erwirbt und entwickelt verschiedene Cannabisanbauprojekte. Das Unternehmen wurde 1998 gegründet und hat seinen Sitz in Calgary, Kanada.
Name | CANNAPHARMARX A DL-,0001 |
CEO | Dominick Colvin |
Sitz | Calgary,
ab USA |
Website | |
Industrie | Chemie |
Börsengang | 16.04.2015 |
Mitarbeiter | 4 |
Ticker Symbole
Börse | Symbol |
---|---|
Otc | CPMD |
Pnk | CPMD |
Assets entdecken
Shareholder von CANNAPHARMARX A DL-,0001 investieren auch in folgende Assets
-
-

-

-

-
-

-

-

-

-